Cargando…
A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia
BACKGROUND: Leprosy Type 1 (T1R) reactions are immune-mediated events leading to nerve damage and preventable disability affecting hands, feet and eyes. Type 1 Reactions are treated with oral corticosteroids. There is little evidence on alternative treatments for patients who do not respond to stero...
Autores principales: | Lambert, Saba M., Alembo, Digafe T., Nigusse, Shimelis D., Yamuah, Lawrence K., Walker, Stephen L., Lockwood, Diana N. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821535/ https://www.ncbi.nlm.nih.gov/pubmed/27046330 http://dx.doi.org/10.1371/journal.pntd.0004502 |
Ejemplares similares
-
Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia
por: Lambert, Saba M., et al.
Publicado: (2016) -
The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions
por: Negera, Edessa, et al.
Publicado: (2018) -
A Phase Two Randomised Controlled Double Blind Trial of High Dose
Intravenous Methylprednisolone and Oral Prednisolone versus Intravenous Normal
Saline and Oral Prednisolone in Individuals with Leprosy Type 1 Reactions and/or
Nerve Function Impairment
por: Walker, Stephen L., et al.
Publicado: (2011) -
Mycophenolate mofetil/ciclosporin/prednisolone: COVID-19 infection: 2 case reports
Publicado: (2021) -
Ciclosporin/prednisolone: COVID-19 infection and Klebsiella pneumoniae septicaemia: case report
Publicado: (2022)